Endocrinology and Metabolism

Original Article

Thyroid
Clinicopathological Features and Molecular Signatures of Lateral Neck Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: Jinsun Lim, Han Sai Lee, Jin-Hyung Heo, Young Shin Song; Endocrinol Metab. 2024;39(2):324-333. Published online April 4, 2024; DOI: https://doi.org/10.3803/EnM.2023.1885

1,051 View
27 Download

Abstract PDF Supplementary Material PubReader ePub: Background
The predictive factors for lateral neck lymph node metastasis (LLNM) in papillary thyroid microcarcinoma (PTMC) remain undetermined. This study investigated the clinicopathological characteristics, transcriptomes, and tumor microenvironment in PTMC according to the LLNM status. We aimed to identify the biomarkers associated with LLNM development.
Methods
We retrospectively reviewed the medical records of patients with PTMC from two independent institutions between 2018 and 2022 (n=597 and n=467). We compared clinicopathological features between patients without lymph node metastasis (N0) and those with LLNM (N1b). Additionally, laser capture microdissection and RNA sequencing were performed on primary tumors from both groups, including metastatic lymph nodes from the N1b group (n=30; 20 primary tumors and 10 paired LLNMs). We corroborated the findings using RNA sequencing data from 16 BRAF-like PTMCs from The Cancer Genome Atlas. Transcriptomic analyses were validated by immunohistochemical staining.
Results
Clinicopathological characteristics, such as male sex, multifocality, extrathyroidal extension, lymphatic invasion, and central node metastasis showed associations with LLNM in PTMCs. Transcriptomic profiles between the N0 and N1b PTMC groups were similar. However, tumor microenvironment deconvolution from RNA sequencing and immunohistochemistry revealed an increased abundance of tumor-associated macrophages, particularly M2 macrophages, in the N1b group.
Conclusion
Patients with PTMC who have a male sex, multifocality, extrathyroidal extension, lymphatic invasion, and central node metastasis exhibited an elevated risk for LLNM. Furthermore, infiltration of M2 macrophages in the tumor microenvironment potentially supports tumor progression and LLNM in PTMCs.

Review Article

Calcium & bone metabolism
Acquired Forms of Fibroblast Growth Factor 23-Related Hypophosphatemic Osteomalacia: Nobuaki Ito, Naoko Hidaka, Hajime Kato; Endocrinol Metab. 2024;39(2):255-261. Published online March 11, 2024; DOI: https://doi.org/10.3803/EnM.2023.1908

1,393 View
77 Download

Abstract PDF PubReader ePub: Fibroblast growth factor 23 (FGF23) is a pivotal humoral factor for the regulation of serum phosphate levels and was first identified in patients with autosomal dominant hypophosphatemic rickets and tumor-induced osteomalacia (TIO), the most common form of acquired FGF23-related hypophosphatemic rickets/osteomalacia (FGF23rHR). After the identification of FGF23, many other inherited and acquired forms of FGF23rHR were reported. In this review article, the detailed features of each acquired FGF23rHR are discussed, including TIO, ectopic FGF23 syndrome with malignancy, fibrous dysplasia/McCune-Albright syndrome, Schimmelpenning-Feuerstein-Mims syndrome/cutaneous skeletal hypophosphatemia syndrome, intravenous iron preparation-induced FGF23rHR, alcohol consumption-induced FGF23rHR, and post-kidney transplantation hypophosphatemia. Then, an approach for the differential diagnosis and therapeutic options for each disorder are concisely introduced. Currently, the majority of endocrinologists might only consider TIO when encountering patients with acquired FGF23rHR; an adequate differential diagnosis can reduce medical costs and invasive procedures such as positron emission tomography/computed tomography and venous sampling to identify FGF23-producing tumors. Furthermore, some acquired FGF23rHRs, such as intravenous iron preparation/alcohol consumption-induced FGF23rHR, require only cessation of drugs or alcohol to achieve full recovery from osteomalacia.

Original Article

Thyroid
Different Molecular Phenotypes of Progression in BRAF- and RAS-Like Papillary Thyroid Carcinoma: Jinsun Lim, Han Sai Lee, Jiyun Park, Kyung-Soo Kim, Soo-Kyung Kim, Yong-Wook Cho, Young Shin Song; Endocrinol Metab. 2023;38(4):445-454. Published online July 18, 2023; DOI: https://doi.org/10.3803/EnM.2023.1702

1,721 View
102 Download

Abstract PDF Supplementary Material PubReader ePub: Background
Papillary thyroid carcinoma (PTC) can be classified into two distinct molecular subtypes, BRAF-like (BL) and RASlike (RL). However, the molecular characteristics of each subtype according to clinicopathological factors have not yet been determined. We aimed to investigate the gene signatures and tumor microenvironment according to clinicopathological factors, and to identify the mechanism of progression in BL-PTCs and RL-PTCs.
Methods
We analyzed RNA sequencing data and corresponding clinicopathological information of 503 patients with PTC from The Cancer Genome Atlas database. We performed differentially expressed gene (DEG), Gene Ontology, and molecular pathway enrichment analyses according to clinicopathological factors in each molecular subtype. EcoTyper and CIBERSORTx were used to deconvolve the tumor cell types and their surrounding microenvironment.
Results
Even for the same clinicopathological factors, overlapping DEGs between the two molecular subtypes were uncommon, indicating that BL-PTCs and RL-PTCs have different progression mechanisms. Genes related to the extracellular matrix were commonly upregulated in BL-PTCs with aggressive clinicopathological factors, such as old age (≥55 years), presence of extrathyroidal extension, lymph node metastasis, advanced tumor-node-metastasis (TNM) stage, and high metastasis-age-completeness of resection- invasion-size (MACIS) scores (≥6). Furthermore, in the deconvolution analysis of tumor microenvironment, cancer-associated fibroblasts were significantly enriched. In contrast, in RL-PTCs, downregulation of immune response and immunoglobulin-related genes was significantly associated with aggressive characteristics, even after adjusting for thyroiditis status.
Conclusion
The molecular phenotypes of cancer progression differed between BL-PTC and RL-PTC. In particular, extracellular matrix and cancer-associated fibroblasts, which constitute the tumor microenvironment, would play an important role in the progression of BL-PTC that accounts for the majority of advanced PTCs.

Review Article

Thyroid
Prenatal Exposure to Per- and Polyfluoroalkyl Substances, Maternal Thyroid Dysfunction, and Child Autism Spectrum Disorder: Hyeong-Moo Shin, Jiwon Oh, Rebecca J. Schmidt, Elizabeth N. Pearce; Endocrinol Metab. 2022;37(6):819-829. Published online November 23, 2022; DOI: https://doi.org/10.3803/EnM.2022.1598

6,394 View
131 Download
2 Web of Science
3 Crossref

Abstract PDF PubReader ePub

Autism spectrum disorder (ASD), with its high economic and societal costs, is a growing public health concern whose prevalence has risen steadily over the last two decades. Although actual increased incidence versus improved diagnosis remains controversial, the increased prevalence of ASD suggests non-inherited factors as likely contributors. There is increasing epidemiologic evidence that abnormal maternal thyroid function during pregnancy is associated with increased risk of child ASD and other neurodevelopmental disorders. Prenatal exposure to endocrine-disrupting chemicals such as per- and polyfluoroalkyl substances (PFAS) is known to disrupt thyroid function and can affect early brain development; thus, thyroid dysfunction is hypothesized to mediate this relationship. The concept of a potential pathway from prenatal PFAS exposure through thyroid dysfunction to ASD etiology is not new; however, the extant literature on this topic is scant. The aim of this review is to evaluate and summarize reports with regard to potential mechanisms in this pathway.

Citations

Citations to this article as recorded by

Endocrine Disruptors and Thyroid Health
Elizabeth N. Pearce
Endocrine Practice.2024; 30(2): 172. CrossRef
Maternal Thyroid Dysfunction During Pregnancy as an Etiologic Factor in Autism Spectrum Disorder: Challenges and Opportunities for Research
Zoe B. Kaplan, Elizabeth N. Pearce, Sun Y. Lee, Hyeong-Moo Shin, Rebecca J. Schmidt
Thyroid®.2024; 34(2): 144. CrossRef
Effects of Endocrine-Disrupting Chemicals on Human Health
Jun Hyung Lee, Sung-Eun Cho
Laboratory Medicine Online.2023; 13(3): 129. CrossRef

Original Article

Clinical Study
Changes in Glucose Metabolism after Adrenalectomy or Treatment with a Mineralocorticoid Receptor Antagonist for Primary Aldosteronism: Yu-Fang Lin, Kang-Yung Peng, Chia-Hui Chang, Ya-Hui Hu, Vin-Cent Wu, Shiu-Dong Chung, Taiwan Primary Aldosteronism Investigation (TAIPAI) Study Group; Endocrinol Metab. 2020;35(4):838-846. Published online December 2, 2020; DOI: https://doi.org/10.3803/EnM.2020.797

5,198 View
131 Download
7 Web of Science
8 Crossref

Abstract PDF PubReader ePub

Background
Data on the effects of excess aldosterone on glucose metabolism are inconsistent. This study compared the changes in glucose metabolism in patients with primary aldosteronism (PA) after adrenalectomy or treatment with a mineralocorticoid receptor antagonist (MRA).
Methods
Overall, 241 patients were enrolled; 153 underwent adrenalectomy and 88 received an MRA. Fasting glucose, homeostatic model assessment of insulin resistance (HOMA-IR), and homeostatic model assessment of β-cell function (HOMA-β) were compared between the treatment groups after 1 year. Plasma aldosterone concentration (PAC) and factors determining HOMA-IR and PAC were evaluated.
Results
No baseline differences were observed between the groups. Fasting insulin, HOMA-IR, and HOMA-β increased in both groups and there were no significant differences in fasting glucose following treatment. Multiple regression analysis showed associations between PAC and HOMA-IR (β=0.172, P=0.017) after treatment. Treatment with spironolactone was the only risk factor associated with PAC >30 ng/dL (odds ratio, 5.2; 95% confidence interval [CI], 2.7 to 10; P<0.001) and conferred a 2.48-fold risk of insulin resistance after 1 year compared with surgery (95% CI, 1.3 to 4.8; P=0.007).
Conclusion
Spironolactone treatment might increase insulin resistance in patients with PA. This strengthened the current recommendation that adrenalectomy is the preferred strategy for patient with positive lateralization test. Achieving a post-treatment PAC of <30 ng/dL for improved insulin sensitivity may be appropriate.

Citations

Citations to this article as recorded by

How should anti-hypertensive medications be adjusted before screening for primary aldosteronism?
Jin-Ying Lu, Yi-Yao Chang, Ting-Wei Lee, Ming-Hsien Wu, Zheng-Wei Chen, Yen-Ta Huang, Tai-Shuan Lai, Leay Kiaw Er, Yen-Hung Lin, Vin-Cent Wu, Hao-Min Cheng, Hsien-Li Kao, Charles Jia-Yin Hou, Kwan-Dun Wu, Szu-Tah Chen, Feng-Hsuan Liu
Journal of the Formosan Medical Association.2024; 123: S91. CrossRef
Diabete e sindrome metabolica nel paziente con iperaldosteronismo primario
Stella Bernardi, Valerio Velardi, Federica De Luca, Giulia Zuolo, Veronica Calabrò, Riccardo Candido, Bruno Fabris
L'Endocrinologo.2024; 25(1): 48. CrossRef
Prevalence, risk factors and evolution of diabetes mellitus after treatment in primary aldosteronism. Results from the SPAIN-ALDO registry
M. Araujo-Castro, M. Paja Fano, B. Pla Peris, M. González Boillos, E. Pascual-Corrales, A. M. García Cano, P. Parra Ramírez, P. Martín Rojas-Marcos, J. G. Ruiz-Sanchez, A. Vicente Delgado, E. Gómez Hoyos, R. Ferreira, I. García Sanz, M. Recasens Sala, R.
Journal of Endocrinological Investigation.2023; 46(11): 2343. CrossRef
Estimated glomerular filtration rate-dip after medical target therapy associated with increased mortality and cardiovascular events in patients with primary aldosteronism
Jia-Yuh Sheu, Shuo-Meng Wang, Vin-Cent Wu, Kuo-How Huang, Chi-Shin Tseng, Yuan-Ju Lee, Yao-Chou Tsai, Yen-Hung Lin, Jeff S. Chueh
Journal of Hypertension.2023; 41(9): 1401. CrossRef
Risk of dementia in primary aldosteronism compared with essential hypertension: a nationwide cohort study
Namki Hong, Kyoung Jin Kim, Min Heui Yu, Seong Ho Jeong, Seunghyun Lee, Jung Soo Lim, Yumie Rhee
Alzheimer's Research & Therapy.2023;[Epub] CrossRef
Secondary diabetes mellitus due to primary aldosteronism
Melpomeni Moustaki, Stavroula A. Paschou, Eleni C. Vakali, Andromachi Vryonidou
Endocrine.2022; 79(1): 17. CrossRef
Serum Cystatin C Levels Could Predict Rapid Kidney Function Decline in A Community-Based Population
Wei-Ching Fang, Hsing-Yu Chen, Shao-Chi Chu, Po-Hsi Wang, Chin-Chan Lee, I-Wen Wu, Chiao-Yin Sun, Heng-Jung Hsu, Chun-Yu Chen, Yung-Chang Chen, Vin-Cent Wu, Heng-Chih Pan
Biomedicines.2022; 10(11): 2789. CrossRef
Recovery from diabetes mellitus in primary aldosteronism patients after adrenalectomy
Yu Liu, Lede Lin, Chi Yuan, Sikui Shen, Yin Tang, Zhihong Liu, Yuchun Zhu, Liang Zhou
BMC Endocrine Disorders.2022;[Epub] CrossRef

Review Articles

Thyroid
Tumor Cells and Cancer-Associated Fibroblasts: A Synergistic Crosstalk to Promote Thyroid Cancer: Laura Fozzatti, Sheue-yann Cheng; Endocrinol Metab. 2020;35(4):673-680. Published online November 9, 2020; DOI: https://doi.org/10.3803/EnM.2020.401

10,959 View
246 Download
19 Web of Science
18 Crossref

Abstract PDF PubReader ePub

Thyroid cancer is the most common endocrine malignancy. Although most thyroid cancer patients are successfully treated and have an excellent prognosis, a percentage of these patients will develop aggressive disease and, eventually, progress to anaplastic thyroid cancer. Since most patients with this type of aggressive thyroid carcinoma will die from the disease, new treatment strategies are urgently needed. Tumor cells live in a complex and dynamic tumor microenvironment composed of different types of stromal cells. Cancer-associated fibroblasts (CAFs) are one of the most important cell components in the tumor microenvironment of most solid tumors, including thyroid cancer. CAFs originate mainly from mesenchymal cells and resident fibroblasts that are activated and reprogrammed in response to paracrine factors and cytokines produced and released by tumor cells. Upon reprogramming, which is distinguished by the expression of different marker proteins, CAFs synthesize and secret soluble factors. The secretome of CAFs directly impacts different functions of tumor cells. This bi-directional interplay between CAFs and tumor cells within the tumor microenvironment ends up fostering tumor cancer progression. CAFs are therefore key regulators of tumor progression and represent an under-explored therapeutic target in thyroid cancer.

Citations

Citations to this article as recorded by

FAPi-Based Agents in Thyroid Cancer: A New Step towards Diagnosis and Therapy? A Systematic Review of the Literature
Priscilla Guglielmo, Pierpaolo Alongi, Lucia Baratto, Miriam Conte, Elisabetta Maria Abenavoli, Ambra Buschiazzo, Greta Celesti, Francesco Dondi, Rossella Filice, Joana Gorica, Lorenzo Jonghi-Lavarini, Riccardo Laudicella, Maria Librando, Flavia Linguanti
Cancers.2024; 16(4): 839. CrossRef
Cancer-associated fibroblasts: protagonists of the tumor microenvironment in gastric cancer
Ece Ozmen, Tevriz Dilan Demir, Gulnihal Ozcan
Frontiers in Molecular Biosciences.2024;[Epub] CrossRef
Co-cultivation of human granulosa cells with ovarian cancer cells leads to a significant increase in progesterone production
Detlef Pietrowski, Martina Grgic, Isabella Haslinger, Julian Marschalek, Christian Schneeberger
Archives of Gynecology and Obstetrics.2023; 307(5): 1593. CrossRef
Secretome of Stromal Cancer-Associated Fibroblasts (CAFs): Relevance in Cancer
Deepshikha Mishra, Debabrata Banerjee
Cells.2023; 12(4): 628. CrossRef
Head-to-Head Comparison of [68Ga]Ga-DOTA.SA.FAPi and [68Ga]Ga-DOTANOC Positron Emission Tomography/Computed Tomography Imaging for the Follow-Up Surveillance of Patients with Medullary Thyroid Cancer
Sanjana Ballal, Madhav Prasad Yadav, Frank Roesch, Shobhana Raju, Swayamjeet Satapathy, Parvind Sheokand, Euy Sung Moon, Marcel Martin, Shipra Awarwal, Madhavi Tripathi, Chandrasekhar Bal
Thyroid®.2023; 33(8): 974. CrossRef
Head-to-head comparison of [68Ga]Ga-DOTA.SA.FAPi with [18F]F-FDG PET/CT in radioiodine-resistant follicular-cell derived thyroid cancers
Sanjana Ballal, Madhav P. Yadav, Frank Roesch, Swayamjeet Satapathy, Euy Sung Moon, Marcel Martin, Nicky Wakade, Parvind Sheokand, Madhavi Tripathi, Kunal R. Chandekar, Shipra Agarwal, Ranjit Kumar Sahoo, Sameer Rastogi, Chandrasekhar Bal
European Journal of Nuclear Medicine and Molecular Imaging.2023; 51(1): 233. CrossRef
Identifying the cancer-associated fibroblast signature to predict the prognosis and immunotherapy response in patients with lung squamous cell carcinoma
Yinhui Zhu, Yingqun Zhu, Sirui Chen, Qian Cai
Computer Methods in Biomechanics and Biomedical Engineering.2023; : 1. CrossRef
Roles and new Insights of Macrophages in the Tumor Microenvironment of Thyroid Cancer
Qi Liu, Wei Sun, Hao Zhang
Frontiers in Pharmacology.2022;[Epub] CrossRef
Rab22a Promotes Epithelial-Mesenchymal Transition in Papillary Thyroid Carcinoma by Activating PI3K/AKT/mTOR Signaling Pathway
Xue Luo, Jinping Wang, Jinxi Lu, Xi Wang, Yuan Miao, Qingchang Li, Xiaoman Li, Liang Wang, Yong Xin Ma
BioMed Research International.2022; 2022: 1. CrossRef
Extracellular vesicles from thyroid cancer harbor a functional machinery involved in extracellular matrix remodeling
Rocío del Carmen Bravo-Miana, María Florencia Soler, Danilo Guillermo Ceschin, Félix Royo, Dana María Negretti-Borga, Mikel Azkargorta, Félix Elortza, María del Mar Montesinos, Claudia Gabriela Pellizas, Juan Manuel Falcón-Pérez, Ana Carolina Donadio
European Journal of Cell Biology.2022; 101(3): 151254. CrossRef
The clinical significance of thyroid hormone-responsive in thyroid carcinoma and its potential regulatory pathway
Zhen-xing Yu, Cheng Xiang, Sheng-gui Xu, Yang-ping Zhang
Medicine.2022; 101(31): e29972. CrossRef
Thyroid Cancer and Fibroblasts
Angelica Avagliano, Giuseppe Fiume, Claudio Bellevicine, Giancarlo Troncone, Alessandro Venuta, Vittoria Acampora, Sabrina De Lella, Maria Rosaria Ruocco, Stefania Masone, Nunzio Velotti, Pietro Carotenuto, Massimo Mallardo, Carmen Caiazza, Stefania Monta
Cancers.2022; 14(17): 4172. CrossRef
TIM3 Expression in Anaplastic-Thyroid-Cancer-Infiltrating Macrophages: An Emerging Immunotherapeutic Target
Luz Maria Palacios, Victoria Peyret, María Estefania Viano, Romina Celeste Geysels, Yair Aron Chocobar, Ximena Volpini, Claudia Gabriela Pellizas, Juan Pablo Nicola, Claudia Cristina Motran, María Cecilia Rodriguez-Galan, Laura Fozzatti
Biology.2022; 11(11): 1609. CrossRef
Recent progress in molecular mechanisms of postoperative recurrence and metastasis of hepatocellular carcinoma
Zhao-Shan Niu, Wen-Hong Wang, Xiao-Jun Niu
World Journal of Gastroenterology.2022; 28(46): 6433. CrossRef
Recent advances in regenerative medicine strategies for cancer treatment
Vahid Mansouri, Nima Beheshtizadeh, Maliheh Gharibshahian, Leila Sabouri, Mohammad Varzandeh, Nima Rezaei
Biomedicine & Pharmacotherapy.2021; 141: 111875. CrossRef
Secreted Factors by Anaplastic Thyroid Cancer Cells Induce Tumor-Promoting M2-like Macrophage Polarization through a TIM3-Dependent Mechanism
Cinthia Carolina Stempin, Romina Celeste Geysels, Sunmi Park, Luz Maria Palacios, Ximena Volpini, Claudia Cristina Motran, Eva Virginia Acosta Rodríguez, Juan Pablo Nicola, Sheue-yann Cheng, Claudia Gabriela Pellizas, Laura Fozzatti
Cancers.2021; 13(19): 4821. CrossRef
Novel Fibroblast Activation Protein Inhibitor-Based Targeted Theranostics for Radioiodine-Refractory Differentiated Thyroid Cancer Patients: A Pilot Study
Sanjana Ballal, Madhav Prasad Yadav, Euy Sung Moon, Frank Roesch, Samta Kumari, Shipra Agarwal, Madhavi Tripathi, Ranjit Kumar Sahoo, Bharadwaj Srinivas Mangu, Avinash Tupalli, Chandrasekhar Bal
Thyroid.2021;[Epub] CrossRef
Emerging Biomarkers in Thyroid Practice and Research
Shipra Agarwal, Andrey Bychkov, Chan-Kwon Jung
Cancers.2021; 14(1): 204. CrossRef

Diabetes
Pathophysiology of Type 2 Diabetes in Koreans: Soo Heon Kwak, Kyong Soo Park; Endocrinol Metab. 2018;33(1):9-16. Published online March 21, 2018; DOI: https://doi.org/10.3803/EnM.2018.33.1.9

5,486 View
111 Download
12 Web of Science
11 Crossref

Abstract PDF PubReader ePub

The pathophysiology of type 2 diabetes is characterized by variable degrees of insulin resistance and impaired insulin secretion. Both genetic and environmental factors serve as etiologic factors. Recent genetic studies have identified at least 83 variants associated with diabetes. A significant number of these loci are thought to be involved in insulin secretion, either through β-cell development or β-cell dysfunction. Environmental factors have changed rapidly during the past half century, and the increased prevalence of obesity and diabetes can be attributed to these changes. Environmental factors may affect epigenetic changes and alter susceptibility to diabetes. A recent epidemiologic study revealed that Korean patients with type 2 diabetes already had impaired insulin secretion and insulin resistance 10 years before the onset of diabetes. Those who developed diabetes showed impaired β-cell compensation with an abrupt decrease in insulin secretion during the last 2 years before diabetes developed. The retrograde trajectory of the disposition index differed according to the baseline subgroups of insulin secretion and insulin sensitivity. We hope that obtaining a more detailed understanding of the perturbations in the major pathophysiologic process of diabetes on the individual level will eventually lead to the implementation of precision medicine and improved patient outcomes.

Citations

Citations to this article as recorded by

Associations between serum perfluoroalkyl and polyfluoroalkyl concentrations and diabetes mellitus in the Korean general population: Insights from the Korean National Environmental Health Survey 2018–2020
Habyeong Kang, Shin-Hye Kim
International Journal of Hygiene and Environmental Health.2024; 259: 114385. CrossRef
Stress-Reducing Psychological Interventions as Adjuvant Therapies for Diabetic Chronic Wounds
Isadora Pombeiro, João Moura, M. Graça Pereira, Eugénia Carvalho
Current Diabetes Reviews.2022;[Epub] CrossRef
Umbilical Cord-Mesenchymal Stem Cell-Conditioned Medium Improves Insulin Resistance in C2C12 Cell
Kyung-Soo Kim, Yeon Kyung Choi, Mi Jin Kim, Jung Wook Hwang, Kyunghoon Min, Sang Youn Jung, Soo-Kyung Kim, Yong-Soo Choi, Yong-Wook Cho
Diabetes & Metabolism Journal.2021; 45(2): 260. CrossRef
Dose-Dependent Effect of Smoking on Risk of Diabetes Remains after Smoking Cessation: A Nationwide Population-Based Cohort Study in Korea
Se Eun Park, Mi Hae Seo, Jung-Hwan Cho, Hyemi Kwon, Yang-Hyun Kim, Kyung-Do Han, Jin-Hyung Jung, Yong-Gyu Park, Eun-Jung Rhee, Won-Young Lee
Diabetes & Metabolism Journal.2021; 45(4): 539. CrossRef
DNA Methylation Changes Associated With Type 2 Diabetes and Diabetic Kidney Disease in an East Asian Population
Hakyung Kim, Jae Hyun Bae, Kyong Soo Park, Joohon Sung, Soo Heon Kwak
The Journal of Clinical Endocrinology & Metabolism.2021; 106(10): e3837. CrossRef
Associations among Obesity Degree, Glycemic Status, and Risk of Heart Failure in 9,720,220 Korean Adults
Eun-Jung Rhee, Hyemi Kwon, Se Eun Park, Kyung-Do Han, Yong-Gyu Park, Yang-Hyun Kim, Won-Young Lee
Diabetes & Metabolism Journal.2020; 44(4): 592. CrossRef
Smoking as a Target for Prevention of Diabetes
Ye Seul Yang, Tae Seo Sohn
Diabetes & Metabolism Journal.2020; 44(3): 402. CrossRef
Clinical characteristics of diabetic ketoacidosis in users and non-users of SGLT2 inhibitors
J.Y. Jeon, S.-K. Kim, K.-S. Kim, S.O. Song, J.-S. Yun, B.-Y. Kim, C.-H. Kim, S.O. Park, S. Hong, D.H. Seo, J.A. Seo, J.H. Noh, D.J. Kim
Diabetes & Metabolism.2019; 45(5): 453. CrossRef
Identifying Pathogenic Variants of Monogenic Diabetes Using Targeted Panel Sequencing in an East Asian Population
Seung Shin Park, Se Song Jang, Chang Ho Ahn, Jung Hee Kim, Hye Seung Jung, Young Min Cho, Young Ah Lee, Choong Ho Shin, Jong Hee Chae, Jae Hyun Kim, Sung Hee Choi, Hak C Jang, Jee Cheol Bae, Jong Cheol Won, Sung-Hoon Kim, Jong-Il Kim, Soo Heon Kwak, Kyong
The Journal of Clinical Endocrinology & Metabolism.2019; 104(9): 4188. CrossRef
Epigenetic Markers and Microbiota/Metabolite-Induced Epigenetic Modifications in the Pathogenesis of Obesity, Metabolic Syndrome, Type 2 Diabetes, and Non-alcoholic Fatty Liver Disease
Daniela Stols-Gonçalves, Luca Schiliró Tristão, Peter Henneman, Max Nieuwdorp
Current Diabetes Reports.2019;[Epub] CrossRef
The cut-off values of surrogate measures for insulin resistance in the Korean population according to the Korean Genome and Epidemiology Study (KOGES)
Bongyoung Kim, Hyun Young Choi, Wonhee Kim, Chiwon Ahn, Juncheol Lee, Jae Guk Kim, Jihoon Kim, Hyungoo Shin, Jae Myung Yu, Shinje Moon, Taulant Muka
PLOS ONE.2018; 13(11): e0206994. CrossRef

Bone Metabolism
Osteoblasts Are the Centerpiece of the Metastatic Bone Microenvironment: Hyo Min Jeong, Sun Wook Cho, Serk In Park; Endocrinol Metab. 2016;31(4):485-492. Published online December 20, 2016; DOI: https://doi.org/10.3803/EnM.2016.31.4.485

3,913 View
47 Download
13 Web of Science
12 Crossref

Abstract PDF PubReader

The tumor microenvironment is comprised of diverse stromal cell populations in addition to tumor cells. Increasing evidence now clearly supports the role of microenvironment stromal cells in tumor progression and metastasis, yet the regulatory mechanisms and interactions among tumor and stromal cells remain to be elucidated. Bone metastasis is the major problem in many types of human malignancies including prostate, breast and lung cancers, and the biological basis of bone metastasis let alone curative approaches are largely undetermined. Among the many types of stromal cells in bone, osteoblasts are shown to be an important player. In this regard, osteoblasts are a key target cell type in the development of bone metastasis, but there are currently no drugs or therapeutic approaches are available that specifically target osteoblasts. This review paper summarizes the current knowledge on osteoblasts in the metastatic tumor microenvironment, aiming to provide clues and directions for future research endeavor.

Citations

Citations to this article as recorded by

Bone marrow adipocytes and lung cancer bone metastasis: unraveling the role of adipokines in the tumor microenvironment
Jian Li, Jialu Wu, Yanni Xie, Xijie Yu
Frontiers in Oncology.2024;[Epub] CrossRef
Circulating biomarkers for diagnosis and therapeutic monitoring in bone metastasis
Min-Kyoung Song, Serk In Park, Sun Wook Cho
Journal of Bone and Mineral Metabolism.2023; 41(3): 337. CrossRef
Mobilization of monocytic myeloid-derived suppressor cells is regulated by PTH1R activation in bone marrow stromal cells
Eun Jung Lee, Kyoung Jin Lee, Seungpil Jung, Kyong Hwa Park, Serk In Park
Bone Research.2023;[Epub] CrossRef
2E‐Decene‐4,6‐diyn‐1‐ol‐acetate inhibits osteoclastogenesis through mitogen‐activated protein kinase‐c‐Fos‐NFATc1 signalling pathways
Young Ran Park, Xiang‐Dong Su, Saroj Kumar Shrestha, Seo Young Yang, Yunjo Soh
Clinical and Experimental Pharmacology and Physiology.2022; 49(3): 341. CrossRef
The let-7f-5p–Nme4 pathway mediates tumor necrosis factor α-induced impairment in osteogenesis of bone marrow-derived mesenchymal stem cells
Ying-Jie Zhao, Zheng-Chao Gao, Xi-Jing He, Jing Li
Biochemistry and Cell Biology.2021; 99(4): 488. CrossRef
Circulating Osteocalcin-Positive Cells as a Novel Diagnostic Biomarker for Bone Metastasis in Breast Cancer Patients
Kyung-Hun Lee, Kyoung Jin Lee, Tae-Yong Kim, Febby Hutomo, Hyun Jin Sun, Gi Jeong Cheon, Serk In Park, Sun Wook Cho, Seock-Ah Im
Journal of Bone and Mineral Research.2020; 35(10): 1838. CrossRef
The Early Results of Vertebral Pathological Compression Fracture of Extra- nodal Lymphoma with HIV-positive Patients Treated by Percutaneous Kyphoplasty
Sheng Sun, Biao Xu, Qiang Zhang, Chang-song Zhao, Rui Ma, Jie He, Yao Zhang
Current HIV Research.2020; 18(4): 248. CrossRef
Sema4D expression and secretion are increased by HIF-1α and inhibit osteogenesis in bone metastases of lung cancer
Wu-gui Chen, Jing Sun, Wei-wei Shen, Si-zhen Yang, Ying Zhang, Xu Hu, Hao Qiu, Shang-cheng Xu, Tong-wei Chu
Clinical & Experimental Metastasis.2019; 36(1): 39. CrossRef
Dual targeting c-met and VEGFR2 in osteoblasts suppresses growth and osteolysis of prostate cancer bone metastasis
Changki Lee, Young Mi Whang, Preston Campbell, Patrick L. Mulcrone, Florent Elefteriou, Sun Wook Cho, Serk In Park
Cancer Letters.2018; 414: 205. CrossRef
Targeting the tumour stroma to improve cancer therapy
Kenneth C. Valkenburg, Amber E. de Groot, Kenneth J. Pienta
Nature Reviews Clinical Oncology.2018; 15(6): 366. CrossRef
Bone Microenvironment and Role of Rank-Rankl-Opg in Breast Cancer Metastasis in Bone
Hongwei Zhang
Journal of Cancer Prevention & Current Research.2017;[Epub] CrossRef
Articles inEndocrinology and Metabolismin 2016
Won-Young Lee
Endocrinology and Metabolism.2017; 32(1): 62. CrossRef

Thyroid
Clinical Relevance of Environmental Factors in the Pathogenesis of Autoimmune Thyroid Disease: Wilmar M. Wiersinga; Endocrinol Metab. 2016;31(2):213-222. Published online May 13, 2016; DOI: https://doi.org/10.3803/EnM.2016.31.2.213

9,240 View
212 Download
89 Web of Science
93 Crossref

Abstract PDF PubReader

Genetic factors contribute for about 70% to 80% and environmental factors for about 20% to 30% to the pathogenesis of autoimmune thyroid disease (AITD). Relatives of AITD patients carry a risk to contract AITD themselves. The 5-year risk can be quantified by the so-called Thyroid Events Amsterdam-score, based on serum thyroid-stimulating hormone, thyroid peroxidase (TPO)-antibodies and family history. Subjects at risk may ask what they can do to prevent development of AITD. This review summarizes what is known about modulation of exposure to environmental factors in terms of AITD prevention. To stop smoking decreases the risk on Graves disease but increases the risk on Hashimoto disease. Moderate alcohol intake provides some protection against both Graves and Hashimoto disease. Low selenium intake is associated with a higher prevalence of thyroid autoimmunity, but evidence that selenium supplementation may lower TPO antibodies and prevent subclinical hypothyroidism remains inconclusive. Low serum vitamin D levels are associated with a higher prevalence of TPO antibodies, but intervention studies with extra vitamin D have not been done yet. Stress may provoke Graves hyperthyroidism but not Hashimoto thyroiditis. Estrogen use have been linked to a lower prevalence of Graves disease. The postpartum period is associated with an increased risk of AITD. Taking together, preventive interventions to diminish the risk of AITD are few, not always feasible, and probably of limited efficacy.

Citations

Citations to this article as recorded by

Trends in Prevalence of Thyroid Dysfunction and its Associations With Mortality Among US Participants, 1988-2012
Xiaowen Zhang, Yong Wang, Hongwei Wang, Xinlin Zhang
The Journal of Clinical Endocrinology & Metabolism.2024; 109(2): e657. CrossRef
The role of medical and organizational measures in improving the quality of early detection and clinical examination of autoimmune thyroiditis among the population of the Republic of Belarus
L. I. Danilova, V. A. Rozhko, I. V. Veyalkin, S. N. Nikanovich, T. M. Sharshakova
Health and Ecology Issues.2024; 20(4): 129. CrossRef
Hyperthyroidism
Layal Chaker, David S Cooper, John P Walsh, Robin P Peeters
The Lancet.2024; 403(10428): 768. CrossRef
A Review of Thyroid Dysfunction Due to COVID-19
Alireza Arefzadeh
Mini-Reviews in Medicinal Chemistry.2024; 24(3): 265. CrossRef
Alteration in kynurenine pathway metabolites in young women with autoimmune thyroiditis
Anna Krupa, Agnieszka Łebkowska, Marcin Kondraciuk, Karol Adam Kaminski, Irina Kowalska
Scientific Reports.2024;[Epub] CrossRef
Association of autoimmune thyroid disease with type 1 diabetes mellitus and its ultrasonic diagnosis and management
Jin Wang, Ke Wan, Xin Chang, Rui-Feng Mao
World Journal of Diabetes.2024; 15(3): 348. CrossRef
Hashimoto’s thyroiditis and coexisting disorders in correlation with HLA status—an overview
Peter Mikosch, Adrian Aistleitner, Markus Oehrlein, Eva Trifina-Mikosch
Wiener Medizinische Wochenschrift.2023; 173(1-2): 41. CrossRef
The management and metabolic characterization: hyperthyroidism and hypothyroidism
Yangyang Wang, YanPing Sun, Bingyou Yang, Qiuhong Wang, Haixue Kuang
Neuropeptides.2023; 97: 102308. CrossRef
Zn and Se abrogate heavy metal mixture induced ovarian and thyroid oxido-inflammatory effects mediated by activation of NRF2-HMOX-1 in female albino rats
Boma F. Eddie-Amadi, Anthonet N. Ezejiofor, Chinna N. Orish, Orish E. Orisakwe
Current Research in Toxicology.2023; 4: 100098. CrossRef
Genetically predicted selenium concentrations and thyroid function: A two‐sample Mendelian randomization study
Hui‐Jun Huang, Shan‐Shan Wang, Ming‐Min Jin, Bin‐Wei Cheng, Yu Liu, Xiao‐Chen Liu, Qiu‐Yan Yu, Xin‐Jun Yang
Clinical Endocrinology.2023; 98(6): 813. CrossRef
Identification of Smoking-Associated Transcriptome Aberration in Blood with Machine Learning Methods
FeiMing Huang, QingLan Ma, JingXin Ren, JiaRui Li, Fen Wang, Tao Huang, Yu-Dong Cai, Bilal Alatas
BioMed Research International.2023; 2023: 1. CrossRef
COVID-induced thyroid autoimmunity
Alessandro Brancatella, Nicola Viola, Ferruccio Santini, Francesco Latrofa
Best Practice & Research Clinical Endocrinology & Metabolism.2023; 37(2): 101742. CrossRef
Associations between vitamin D levels and dietary patterns in patients with Hashimoto’s thyroiditis
Dean Kaličanin, Maja Cvek, Ana Barić, Veselin Škrabić, Ante Punda, Vesna Boraska Perica
Frontiers in Nutrition.2023;[Epub] CrossRef
COMPARATIVE MORPHOLOGY OF THE THYROID GLAND
L. O. Sviatotska
Bulletin of Problems Biology and Medicine.2023; 1(2): 386. CrossRef
Evaluation and epigenetic impact of B12, vitamin D, folic acid and anemia in Hashimoto's thyroiditis: a clinical and molecular docking study
Elif Sibel ASLAN, Savaş GÜR
Journal of Health Sciences and Medicine.2023; 6(4): 705. CrossRef
Interactions between Polygenetic Variants and Lifestyle Factors in Hypothyroidism: A Hospital-Based Cohort Study
Da Sol Kim, Sunmin Park
Nutrients.2023; 15(17): 3850. CrossRef
Do Dietary Supplements Affect Inflammation, Oxidative Stress, and Antioxidant Status in Adults with Hypothyroidism or Hashimoto’s Disease?—A Systematic Review of Controlled Trials
Katarzyna Kubiak, Maria Karolina Szmidt, Joanna Kaluza, Agnieszka Zylka, Ewa Sicinska
Antioxidants.2023; 12(10): 1798. CrossRef
Identification and Preliminary Clinical Validation of Key Extracellular Proteins as the Potential Biomarkers in Hashimoto’s Thyroiditis by Comprehensive Analysis
Zihan Xi, Tinglin Yang, Tao Huang, Jun Zhou, Peng Yang
Biomedicines.2023; 11(12): 3127. CrossRef
An examination of retinal findings with optical coherence tomography in hypothyroidism patients with vitamin D deficiency: A comparative study
Samet Sayılan, Dila Kırağı, Mehmet Tayfun Arslan
Journal of Clinical Medicine of Kazakhstan.2023; 20(6): 36. CrossRef
The role of IL-4 −590 (C>T) Gene as diagnostic biomarker of Hashimoto thyroiditis disease patients in AL-Najaf provenance /Iraq
Sarah Hasan Kadhum AL-Huchaimi, Mahdi Hussain AL-Ammar, Sabah N. AL-Fatlawi
Al-Kufa University Journal for Biology.2023; 15(3): 14. CrossRef
Early life stress in women with autoimmune thyroid disorders
Alessia Corso, Hermann Engel, Fabienne Müller, Serena Fiacco, Laura Mernone, Elena Gardini, Ulrike Ehlert, Susanne Fischer
Scientific Reports.2023;[Epub] CrossRef
Protective Effects of Selenium and Zinc Against Nickel Chloride–Induced Hormonal Changes and Oxidative Damage in Thyroid of Pregnant Rats
Imane Salah, Ounassa Adjroud, Awatef Elwej
Biological Trace Element Research.2022; 200(5): 2183. CrossRef
Effects of animal protein intake during pregnancy on autoimmune thyroiditis in pregnant women with mild iodine deficiency
Zhengyuan Wang, Jiaying Shen, Qi Song, Xueying Cui, Zehuan Shi, Jin Su, Jiajie Zang
Journal of Human Nutrition and Dietetics.2022; 35(3): 542. CrossRef
Positive antithyroid antibody predicts severity of neuromyelitis optica spectrum disorder in children
Liang Huo, Hua Wang, Yujun Yuan, Jian Gao, Xueyan Liu
Multiple Sclerosis and Related Disorders.2022; 57: 103425. CrossRef
Seasonality of month of birth in patients with autoimmune endocrine diseases: A systematic review
Ana M. Ramos-Leví, Gloria Collado, Monica Marazuela
Endocrinología, Diabetes y Nutrición.2022; 69(10): 779. CrossRef
Are ethnic differences, urinary iodine status, lead and cadmium exposure associated with thyroid autoimmunity and hypothyroid status? A cross-sectional study
Yi Chen, Qian Xiang, Ningjian Wang, Wen Zhang, Chunfang Zhu, Yuying Wang, Heng Wan, Jing Cheng, Kun Zhang, Yan Cai, Yingli Lu
BMJ Open.2022; 12(2): e056909. CrossRef
The Association of Thyroid Nodules With Blood Trace Elements Identified in a Cross-Section Study
Huixian Zeng, Yuanyuan Hu, Yaosheng Luo, Yanshi Ye, Cheng Song, Genfeng Yu, Zhi Chen, Siyang Liu, Yongqian Liang, Lingling Liu, Heng Wan, Jie Shen
Frontiers in Nutrition.2022;[Epub] CrossRef
Nutritional Management of Thyroiditis of Hashimoto
Yana Danailova, Tsvetelina Velikova, Georgi Nikolaev, Zorka Mitova, Alexander Shinkov, Hristo Gagov, Rossitza Konakchieva
International Journal of Molecular Sciences.2022; 23(9): 5144. CrossRef
Association Between Vitamin D Deficiency and Autoimmune Thyroid Disorder: A Systematic Review
Sabah A Khozam, Abdulhadi M Sumaili, Mohammed A Alflan, Rawan As'ad Salameh Shawabkeh
Cureus.2022;[Epub] CrossRef
Metabolic Characteristics of Hashimoto’s Thyroiditis Patients and the Role of Microelements and Diet in the Disease Management—An Overview
Aniceta A. Mikulska, Marta Karaźniewicz-Łada, Dorota Filipowicz, Marek Ruchała, Franciszek K. Główka
International Journal of Molecular Sciences.2022; 23(12): 6580. CrossRef
Predictors of autoimmune thyroid disease
Carol Cardona Attard, W. C. Candy Sze, Sandro Vella
Baylor University Medical Center Proceedings.2022; 35(5): 608. CrossRef
Selenium Status and Supplementation Effects in Pregnancy—A Study on Mother–Child Pairs from a Single-Center Cohort
Dorota Filipowicz, Ewelina Szczepanek-Parulska, Małgorzata Kłobus, Krzysztof Szymanowski, Thilo Samson Chillon, Sabrina Asaad, Qian Sun, Aniceta A. Mikulska-Sauermann, Marta Karaźniewicz-Łada, Franciszek K. Główka, Dominika Wietrzyk, Lutz Schomburg, Marek
Nutrients.2022; 14(15): 3082. CrossRef
Inflammasome activation as a link between obesity and thyroid disorders: Implications for an integrated clinical management
Rosario Le Moli, Veronica Vella, Dario Tumino, Tommaso Piticchio, Adriano Naselli, Antonino Belfiore, Francesco Frasca
Frontiers in Endocrinology.2022;[Epub] CrossRef
Seasonality of month of birth in patients with autoimmune endocrine diseases: A systematic review
Ana M. Ramos-Leví, Gloria Collado, Monica Marazuela
Endocrinología, Diabetes y Nutrición (English ed.).2022; 69(10): 779. CrossRef
Impact of iodine intake on the pathogenesis of autoimmune thyroid disease in children and adults
Iyshwarya Bhaskar Kalarani, Ramakrishnan Veerabathiran
Annals of Pediatric Endocrinology & Metabolism.2022; 27(4): 256. CrossRef
Morphological features of thyroid benign focal neoplasms in Graves’ disease
Yu.V. Buldygina, A.V. Zelinskaya, L.Yu. Zurnadzhy, Yu.M. Tarashchenko, S.L. Shlyakhtych, M.D. Tronko
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2022; 18(4): 213. CrossRef
Onset of Marine-Lenhart syndrome and Graves’ ophthalmopathy in a female patient treated with alemtuzumab for multiple sclerosis
Rosario Le Moli, Marco Russo, Pasqualino Malandrino, Veronica Vella, Antonino Belfiore, Francesco Frasca
Hormones.2021; 20(1): 161. CrossRef
Limited Genetic Overlap Between Overt Hashimoto’s Thyroiditis and Graves’ Disease in Twins: A Population-based Study
Jakob Skov, Jan Calissendorff, Daniel Eriksson, Patrik Magnusson, Olle Kämpe, Sophie Bensing, Ralf Kuja-Halkola
The Journal of Clinical Endocrinology & Metabolism.2021; 106(4): e1101. CrossRef
DNA Methylation Patterns in the HLA-DPB1 and PDCD1LG2 Gene Regions in Patients with Autoimmune Thyroiditis from Different Water Iodine Areas
Siyuan Wan, Lixiang Liu, Bingxuan Ren, Mengying Qu, Huaiyong Wu, Wen Jiang, Xiaoming Wang, Hongmei Shen
Thyroid.2021; 31(11): 1741. CrossRef
Персоналізація лікування хвороби Грейвса на підставі клініко- імунологічних характеристик перебігу захворювання
Yu.V. Buldygina, S.L. Shlyakhtych, H.M. Terekhova, T.V. Fed’ko, V.M. Klochkova, L.S. Strafun, Z.H. Lysova, I.I. Savos’ko
Endokrynologia.2021; 26(4): 409. CrossRef
Parity and Incidence of Thyroid Autoimmunity: A Population-Based Tehran Thyroid Study
Miralireza Takyar, Maryam Rahmani, Atieh Amouzegar, Elham Madreseh, Maryam Tohidi, Ladan Mehran, Fereidoun Azizi
Thyroid.2020; 30(8): 1186. CrossRef
Immunomodulatory effect of vitamin D and its potential role in the prevention and treatment of thyroid autoimmunity: a narrative review
D. Gallo, L. Mortara, M. B. Gariboldi, S. A. M. Cattaneo, S. Rosetti, L. Gentile, D. M. Noonan, P. Premoli, C. Cusini, M. L. Tanda, L. Bartalena, E. Piantanida
Journal of Endocrinological Investigation.2020; 43(4): 413. CrossRef
Hashimoto Thyreoiditis, therapeutische Optionen und extrathyreoidale Assoziationen – ein aktueller Überblick
Eva Petnehazy, Wolfgang Buchinger
Wiener Medizinische Wochenschrift.2020; 170(1-2): 26. CrossRef
Pathophysiological Role and Therapeutic Implications of Vitamin D in Autoimmunity: Focus on Chronic Autoimmune Diseases
Mattia Bellan, Laura Andreoli, Chiara Mele, Pier Paolo Sainaghi, Cristina Rigamonti, Silvia Piantoni, Carla De Benedittis, Gianluca Aimaretti, Mario Pirisi, Paolo Marzullo
Nutrients.2020; 12(3): 789. CrossRef
Thyroxine-binding globulin, peripheral deiodinase activity, and thyroid autoantibody status in association of phthalates and phenolic compounds with thyroid hormones in adult population
Sohyeon Choi, Min Joo Kim, Young Joo Park, Sunmi Kim, Kyungho Choi, Gi Jeong Cheon, Yoon Hee Cho, Hye Li Jeon, Jiyoung Yoo, Jeongim Park
Environment International.2020; 140: 105783. CrossRef
Immunomodulatory Effects of Vitamin D in Thyroid Diseases
Chiara Mele, Marina Caputo, Alessandro Bisceglia, Maria Teresa Samà, Marco Zavattaro, Gianluca Aimaretti, Loredana Pagano, Flavia Prodam, Paolo Marzullo
Nutrients.2020; 12(5): 1444. CrossRef
Significance of arsenic and lead in Hashimoto's thyroiditis demonstrated on thyroid tissue, blood, and urine samples
Aleksandar Stojsavljević, Branislav Rovčanin, Jovana Jagodić, Danijela Drašković Radojković, Ivan Paunović, Marija Gavrović-Jankulović, Dragan Manojlović
Environmental Research.2020; 186: 109538. CrossRef
Graves’ disease: Epidemiology, genetic and environmental risk factors and viruses
Alessandro Antonelli, Silvia Martina Ferrari, Francesca Ragusa, Giusy Elia, Sabrina Rosaria Paparo, Ilaria Ruffilli, Armando Patrizio, Claudia Giusti, Debora Gonnella, Alfonso Cristaudo, Rudy Foddis, Yehuda Shoenfeld, Poupak Fallahi
Best Practice & Research Clinical Endocrinology & Metabolism.2020; 34(1): 101387. CrossRef
Vitamin D deficiency and thyroid autoantibody fluctuations in patients with Graves’ disease – A mere coincidence or a real relationship?
Maria Teresa Płazińska, Agata Czarnywojtek, Nadia Sawicka-Gutaj, Małgorzata Zgorzalewicz-Stachowiak, Barbara Czarnocka, Paweł Gut, Maria Karlinska, Marta Fichna, Adam Stachowski, Marek Ruchała, Iwona Krela-Kaźmierczak, Leszek Królicki
Advances in Medical Sciences.2020; 65(1): 39. CrossRef
An eight-year-old girl with autoimmune polyglandular syndrome type3A that developed during the course of primary Epstein–Barr virus (EBV) infection: clinical implication of EBV in autoimmune thyroid disease
Shizuka Kirino, Hisae Nakatani, Aoi Honma, Asami Shinbo, Keiko Onda, Mari Okada, Masako Imai, Natsuko Suzuki, Akihiro Oshiba, Masayuki Nagasawa
Immunological Medicine.2020; 43(1): 57. CrossRef
Exploring the role of copper and selenium in the maintenance of normal thyroid function among healthy Koreans
Min Joo Kim, Soo Chin Kim, Soie Chung, Serim Kim, Ji Won Yoon, Young Joo Park
Journal of Trace Elements in Medicine and Biology.2020; 61: 126558. CrossRef
A comparison of serum zinc levels in melasma and non-melasma patients: a preliminary study of thyroid dysfunction
Indina Sastrini Sekarnesia, Irma Bernadette S. Sitohang, Triana Agustin, Wismandari Wisnu, Aida S. D. Hoemardani
Acta Dermatovenerologica Alpina Pannonica et Adriatica.2020;[Epub] CrossRef
Hashimoto's thyroiditis: An update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation
Massimo Ralli, Diletta Angeletti, Marco Fiore, Vittorio D'Aguanno, Alessandro Lambiase, Marco Artico, Marco de Vincentiis, Antonio Greco
Autoimmunity Reviews.2020; 19(10): 102649. CrossRef
Vitamin D and Autoimmune Thyroid Disease—Cause, Consequence, or a Vicious Cycle?
Inês Henriques Vieira, Dírcea Rodrigues, Isabel Paiva
Nutrients.2020; 12(9): 2791. CrossRef
New Insights into Mechanisms of Endocrine-Disrupting Chemicals in Thyroid Diseases: The Epigenetic Way
Letizia Pitto, Francesca Gorini, Fabrizio Bianchi, Elena Guzzolino
International Journal of Environmental Research and Public Health.2020; 17(21): 7787. CrossRef
Genotype association of IP6K3 gene with Hashimoto’s thyroiditis in Algerian population (Aures region)
Warda Kherrour, Dean Kalicanin, Luka Brčić, Leila Hambaba, Mouloud Yahia, Souheyla Benbia, Vesna Boraska Perica
Egyptian Journal of Medical Human Genetics.2020;[Epub] CrossRef
TOTAL ANTIOXIDANT ACTIVITY AND MANGANESE SUPEROXIDE DISMUTASE IN COMORBIDITY OF GASTROESOPHAGEAL REFLUX DISEASE AND AUTOIMMUNE THYROIDITIS IN STUDENT POPULATION
Tamara M. Pasiieshvili, Natalia M. Zhelezniakova, Lyudmila M. Pasiyeshvili, Olga M. Kovalyova
Wiadomości Lekarskie.2020; 73(12): 2644. CrossRef
Vitamin B12 and Vitamin D Levels in Patients with Autoimmune Hypothyroidism and Their Correlation with Anti-Thyroid Peroxidase Antibodies
Hanife Şerife Aktaş
Medical Principles and Practice.2020; 29(4): 364. CrossRef
Increased Risk of Thyroid Dysfunction Among Patients With Rheumatoid Arthritis
Qian Li, Bin Wang, Kaida Mu, Jing Zhang, Yanping Yang, Wei Yao, Jie Zhu, Jin-an Zhang
Frontiers in Endocrinology.2019;[Epub] CrossRef
Association between thyroglobulin polymorphisms and autoimmune thyroid disease: a systematic review and meta-analysis of case–control studies
Ming-Liang Zhang, Dong-ming Zhang, Cai-E. Wang, Xiao-Long Chen, Fang-Zhou Liu, Jian-Xue Yang
Genes & Immunity.2019; 20(6): 484. CrossRef
Changes in glucose‐lipid metabolism, insulin resistance, and inflammatory factors in patients with autoimmune thyroid disease
Yi Lei, Jun Yang, Hua Li, Haihua Zhong, Qin Wan
Journal of Clinical Laboratory Analysis.2019;[Epub] CrossRef
Evaluation of Qualitative Dietary Protocol (Diet4Hashi) Application in Dietary Counseling in Hashimoto Thyroiditis: Study Protocol of a Randomized Controlled Trial
Natalia Wojtas, Lidia Wadolowska, Elżbieta Bandurska-Stankiewicz
International Journal of Environmental Research and Public Health.2019; 16(23): 4841. CrossRef
Sjögren’s Syndrome and Autoimmune Thyroid Disease: Two Sides of the Same Coin
Juan-Manuel Anaya, Paula Restrepo-Jiménez, Yhojan Rodríguez, Mónica Rodríguez-Jiménez, Yeny Acosta-Ampudia, Diana M. Monsalve, Yovana Pacheco, Carolina Ramírez-Santana, Nicolás Molano-González, Rubén D. Mantilla
Clinical Reviews in Allergy & Immunology.2019; 56(3): 362. CrossRef
Disease Presentation and Remission Rate in Graves Disease Treated With Antithyroid Drugs: is Gender Really A Factor?
Talia Diker-Cohen, Hadar Duskin-Bitan, Ilan Shimon, Dania Hirsch, Amit Akirov, Gloria Tsvetov, Eyal Robenshtok
Endocrine Practice.2019; 25(1): 43. CrossRef
IRAK2 and TLR10 confer risk of Hashimoto’s disease: a genetic association study based on the Han Chinese population
Miao Li, Wei Han, Li Zhu, Jue Jiang, Wei Qu, Lei Zhang, Liang Jia, Qi Zhou
Journal of Human Genetics.2019; 64(7): 617. CrossRef
Environmental exposure to pesticides and risk of thyroid diseases
Mar Requena, Antonia López-Villén, Antonio F. Hernández, Tesifón Parrón, Ángela Navarro, Raquel Alarcón
Toxicology Letters.2019; 315: 55. CrossRef
Determining the Level of Knowledge about Graves’ Disease: Single-Center Results
Hande Peynirci, Çiğdem Uzuntepe Aksu, Akif Doğan, Canan Ersoy
Ankara Medical Journal.2019;[Epub] CrossRef
Association between lifestyle and thyroid dysfunction: a cross-sectional epidemiologic study in the She ethnic minority group of Fujian Province in China
Yanling Huang, Liangchun Cai, Yuanyuan Zheng, Jinxing Pan, Liantao Li, Liyao Zong, Wei Lin, Jixing Liang, Huibin Huang, Junping Wen, Gang Chen
BMC Endocrine Disorders.2019;[Epub] CrossRef
Vitamin D Receptor Gene Polymorphisms and Autoimmune Thyroiditis: Are They Associated with Disease Occurrence and Its Features?
Adam Maciejewski, Michał J. Kowalczyk, Waldemar Herman, Adam Czyżyk, Marta Kowalska, Ryszard Żaba, Katarzyna Łącka
BioMed Research International.2019; 2019: 1. CrossRef
Diagnosis of Graves’ disease – laboratory tests and possible difficulties in interpretation
Agata Maria Kalicka
Diagnostyka Laboratoryjna.2019; 55(2): 121. CrossRef
The influence of single-nucleotide polymorphisms of interleukin-1β -511 and +3954 on the susceptibility to Hashimoto’s thyroiditis in Egyptian women: immune-endocrine interactions
Nearmeen M. Rashad, Manar H. Soliman, Mayada M. Mousa, Azza H. Abd El-Fatah
The Egyptian Journal of Internal Medicine.2019; 31(1): 14. CrossRef
Global epidemiology of hyperthyroidism and hypothyroidism
Peter N. Taylor, Diana Albrecht, Anna Scholz, Gala Gutierrez-Buey, John H. Lazarus, Colin M. Dayan, Onyebuchi E. Okosieme
Nature Reviews Endocrinology.2018; 14(5): 301. CrossRef
Selenoproteins in human body: focus on thyroid pathophysiology
Ana Valea, Carmen Emanuela Georgescu
Hormones.2018; 17(2): 183. CrossRef
Epidemiology of hyperthyroidism in Iran: a systematic review and meta-analysis
Sayed Mahmoud Sajjadi-Jazi, Farshad Sharifi, Mehdi Varmaghani, Hamidreza Aghaei Meybodi, Farshad Farzadfar, Bagher Larijani
Journal of Diabetes & Metabolic Disorders.2018; 17(2): 345. CrossRef
The effect of vitamin D supplementation on thyroid autoantibody levels in the treatment of autoimmune thyroiditis: a systematic review and a meta-analysis
Su Wang, Yaping Wu, Zhihua Zuo, Yijing Zhao, Kun Wang
Endocrine.2018; 59(3): 499. CrossRef
Thyroid disorders in alemtuzumab-treated multiple sclerosis patients: a Belgian consensus on diagnosis and management
Brigitte Decallonne, Emmanuel Bartholomé, Valérie Delvaux, Miguel D’haeseleer, Souraya El Sankari, Pierrette Seeldrayers, Bart Van Wijmeersch, Chantal Daumerie
Acta Neurologica Belgica.2018; 118(2): 153. CrossRef
Synergistic interactions of Angiotensin Converting Enzyme (ACE) gene and Apolipoprotein E (APOE) gene polymorphisms with T1DM susceptibility in south India
Padma-Malini Ravi, Rathika Chinniah, Ramgopal Sivanadham, Murali Vijayan, Dharmarajan Pannerselvam, S. Pushkala, Balakrishnan Karuppiah
Meta Gene.2018; 18: 39. CrossRef
The effect of obesity and dietary habits on oxidative stress in Hashimoto’s thyroiditis
Maria Giannakou, Katerina Saltiki, Emily Mantzou, Eleni Loukari, Georgios Philippou, Konstantinos Terzidis, Charalampos Stavrianos, Miltiades Kyprianou, Theodora Psaltopoulou, Kalliopi Karatzi, Maria Alevizaki
Endocrine Connections.2018; 7(9): 990. CrossRef
Interaction of HLA-DRB1* alleles and CTLA4 (+ 49 AG) gene polymorphism in Autoimmune Thyroid Disease
Sivanadham Ramgopal, Chinniah Rathika, Malini Ravi Padma, Vijayan Murali, Kannan Arun, Mohamed Nainar Kamaludeen, Karuppiah Balakrishnan
Gene.2018; 642: 430. CrossRef
New insights into the etiopathogenesis of Hashimoto's Thyroiditis: The role of genetics and epigenetics
Massimo Ralli, Armando De Virgilio, Marco Artico, Lucia Longo, Marco de Vincentiis, Antonio Greco
Autoimmunity Reviews.2018; 17(10): 1065. CrossRef
Comorbidity of autoimmune thyroid disorders and psychiatric disorders during the postpartum period: a Danish nationwide register-based cohort study
V. Bergink, V. J. M. Pop, P. R. Nielsen, E. Agerbo, T. Munk-Olsen, X. Liu
Psychological Medicine.2018; 48(8): 1291. CrossRef
Spontaneous conversion from Graves’ disease to Hashimoto’s thyroiditis: a case report
Muharrem Bayrak, Kenan Çadırcı, Emine Kartal Baykan, Ünsal Aydın, Ayşe Çarlıoğlu
Ortadoğu Tıp Dergisi.2018; 10(1): 81. CrossRef
Association of established hypothyroidism-associated genetic variants with Hashimoto’s thyroiditis
A. Barić, L. Brčić, S. Gračan, V. Torlak Lovrić, I. Gunjača, M. Šimunac, M. Brekalo, M. Boban, O. Polašek, M. Barbalić, T. Zemunik, A. Punda, V. Boraska Perica
Journal of Endocrinological Investigation.2017; 40(10): 1061. CrossRef
Immune Response of Laying Hens Exposed to 30 ppm Ammonia for 25 Weeks
H. Chen, F.F. Yan, J.Y. Hu, Yanan Wu, C.M. Tucker, A.R. Green, H.W. Cheng
International Journal of Poultry Science.2017; 16(4): 139. CrossRef
Dietary Factors Associated with Plasma Thyroid Peroxidase and Thyroglobulin Antibodies
Antonela Matana, Vesela Torlak, Dubravka Brdar, Marijana Popović, Bernarda Lozić, Maja Barbalić, Vesna Boraska Perica, Ante Punda, Ozren Polašek, Caroline Hayward, Tatijana Zemunik
Nutrients.2017; 9(11): 1186. CrossRef
Articles inEndocrinology and Metabolismin 2016
Won-Young Lee
Endocrinology and Metabolism.2017; 32(1): 62. CrossRef
Does vitamin D play a role in autoimmune endocrine disorders? A proof of concept
Barbara Altieri, Giovanna Muscogiuri, Luigi Barrea, Chantal Mathieu, Carla V. Vallone, Luca Mascitelli, Giorgia Bizzaro, Vincenzo M. Altieri, Giacomo Tirabassi, Giancarlo Balercia, Silvia Savastano, Nicola Bizzaro, Cristina L. Ronchi, Annamaria Colao, Alf
Reviews in Endocrine and Metabolic Disorders.2017; 18(3): 335. CrossRef
A case‐control study of the association between ulcerative colitis and hyperthyroidism in an Asian population
Ming‐Chieh Tsai, Herng‐Ching Lin, Cha‐Ze Lee
Clinical Endocrinology.2017; 86(6): 825. CrossRef
Hashimoto's thyroiditis: relative recurrence risk ratio and implications for screening of first‐degree relatives
Nikita Bothra, Nalini Shah, Manjunath Goroshi, Swati Jadhav, Sheetal Padalkar, Hemangini Thakkar, Gurudayal Singh Toteja, Vyankatesh Shivane, Anurag Lila, Tushar Bandgar
Clinical Endocrinology.2017; 87(2): 201. CrossRef
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature
Dilia Giuggioli, M. Colaci, G. Cassone, P. Fallahi, F. Lumetti, A. Spinella, F. Campomori, A. Manfredi, C. U. Manzini, A. Antonelli, C. Ferri
Clinical Rheumatology.2017; 36(3): 583. CrossRef
Are Perinatal Events Risk Factors for Childhood Thyroid Autoimmunity?
Berglind Jonsdottir, Markus Lundgren, Sara Wallengren, Åke Lernmark, Ida Jönsson, Helena Elding Larsson
European Thyroid Journal.2017; 6(6): 298. CrossRef
Variants of Interleukin-22 Gene Confer Predisposition to Autoimmune Thyroid Disease
Rong-hua Song, Qian Li, Wen Wang, Qiu-ming Yao, Xiao-qing Shao, Jin-an Zhang
International Journal of Endocrinology.2017; 2017: 1. CrossRef
Environmental Issues in Thyroid Diseases
Silvia Martina Ferrari, Poupak Fallahi, Alessandro Antonelli, Salvatore Benvenga
Frontiers in Endocrinology.2017;[Epub] CrossRef

Original Article

Protective Effects of Inducible HO-1 on Oxygen Toxicity in Rat Brain Endothelial Microvessel Cells: Seung-Jun Yoo, Neal K. Nakra, Gabriele V. Ronnett, Cheil Moon; Endocrinol Metab. 2014;29(3):356-362. Published online September 25, 2014; DOI: https://doi.org/10.3803/EnM.2014.29.3.356

3,558 View
31 Download
7 Web of Science
6 Crossref

Abstract PDF PubReader

Background

Reperfusion in ischemia is believed to generate cytotoxic oxidative stress, which mediates reperfusion injury. These stress conditions can initiate lipid peroxidation and damage to proteins, as well as promote DNA strand breaks. As biliverdin and bilirubin produced by heme oxygenase isoform 1 (HO-1) have antioxidant properties, the production of both antioxidants by HO-1 may help increase the resistance of the ischemic brain to oxidative stress. In the present study, the survival effect of HO-1 was confirmed using hemin.

Methods

To confirm the roles of HO-1, carbon monoxide, and cyclic guanosine monophosphate further in the antioxidant effect of HO-1 and bilirubin, cells were treated with cycloheximide, desferoxamine, and zinc deuteroporphyrin IX 2,4 bis glycol, respectively.

Results

HO-1 itself acted as an antioxidant. Furthermore, iron, rather than carbon monoxide, was involved in the HO-1-mediated survival effect. HO-1 activity was also important in providing bilirubin as an antioxidant.

Conclusion

Our results suggested that HO-1 helped to increase the resistance of the ischemic brain to oxidative stress.

Citations

Citations to this article as recorded by

The Effects of Naringin on Cigarette Smoke-Induced Dynamic Changes in Oxidation/Antioxidant System in Lung of Mice
Pan Chen, Ziting Xiao, Hao Wu, Yonggang Wang, Weiwei Su, Peibo Li
Natural Product Communications.2020; 15(8): 1934578X2094723. CrossRef
Antioxidation Effect of Simvastatin in Aorta and Hippocampus: A Rabbit Model Fed High-Cholesterol Diet
Guangyin Zhang, Ming Li, Yinzhi Xu, Li Peng, Cui Yang, Yanan Zhou, Junping Zhang
Oxidative Medicine and Cellular Longevity.2016; 2016: 1. CrossRef
Vasculoprotective Effects of 3-Hydroxybenzaldehyde against VSMCs Proliferation and ECs Inflammation
Byung Soo Kong, Soo Jung Im, Yang Jong Lee, Yoon Hee Cho, Yu Ri Do, Jung Woo Byun, Cheol Ryong Ku, Eun Jig Lee, Maria Cristina Vinci
PLOS ONE.2016; 11(3): e0149394. CrossRef
Heme oxygenase-1-derived bilirubin protects endothelial cells against high glucose-induced damage
Meihua He, Mariapaola Nitti, Sabrina Piras, Anna Lisa Furfaro, Nicola Traverso, Maria Adelaide Pronzato, Giovanni E. Mann
Free Radical Biology and Medicine.2015; 89: 91. CrossRef
Articles in 'Endocrinology and Metabolism' in 2014
Won-Young Lee
Endocrinology and Metabolism.2015; 30(1): 47. CrossRef
Involvement of the Heme-Oxygenase Pathway in the Antiallodynic and Antihyperalgesic Activity of Harpagophytum procumbens in Rats
Carmela Parenti, Giuseppina Aricò, Santina Chiechio, Giulia Di Benedetto, Rosalba Parenti, Giovanna Scoto
Molecules.2015; 20(9): 16758. CrossRef

First
Prev
Page of 1
Next
Last

Search